Elevance Health Q1 2020 Earnings Report
Key Takeaways
Anthem, Inc. reported a strong first quarter, marked by a 20.7% increase in operating revenue to $29.4 billion, driven by pharmacy product revenue from IngenioRx and higher premium revenue. Medical enrollment reached 42.1 million members, a 3.2% increase year-over-year. The company is focused on increasing access and coverage, adapting tools and policies, leveraging data analytics, and delivering outreach and relief during the COVID-19 pandemic.
Operating revenue increased by 20.7% to $29.4 billion, driven by pharmacy product revenue and premium increases.
Medical enrollment grew to 42.1 million members, a 3.2% increase from the previous year.
GAAP net income per share was $5.94, while adjusted net income per share was $6.48.
Anthem committed $50 million from the Anthem Foundation for COVID-19 response and recovery efforts.
Elevance Health
Elevance Health
Elevance Health Revenue by Segment
Forward Guidance
Anthem expects GAAP net income to be greater than $21.00 per share and adjusted net income to be greater than $22.30 per share for the full year 2020. Due to the uncertainty caused by COVID-19, the company withdrew all other previously issued financial guidance metrics for 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income